| |
| |
|
| Insider
Information: |
Blixt Charles A |
| Relationship: |
|
| City: |
Winston-Salem |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
36,203 |
|
|
Indirect Shares
|
909,094 |
|
|
| Direct
Value |
$1,624,696 |
|
|
|
Indirect Value
|
$464,820 |
|
|
| Total
Shares |
945,297 |
|
|
| Total
Value |
$2,089,516 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Reynolds American Inc |
RAI |
EVP and General Counsel |
2005-12-21 |
7,167 |
2004-07-30 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
2014-12-11 |
10,000 |
2006-04-18 |
909,094 |
Premium* |
|
|
Krispy Kreme Doughnuts Inc |
KKD |
Director |
2015-03-27 |
0 |
2006-11-30 |
0 |
Premium* |
|
|
Lamb Weston Holdings, Inc. |
LW |
|
2023-10-13 |
19,036 |
2017-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LW |
Lamb Weston Holdings, Inc... |
|
– • – |
2023-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,043 |
19,036 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
|
– • – |
2022-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
16,836 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2021-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,807 |
14,784 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2020-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,912 |
11,859 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800 |
9,851 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2018-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,911 |
7,989 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2017-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21 |
6,045 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2017-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,528 |
6,025 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2017-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10 |
2,497 |
0 |
- |
|
| LW |
Lamb Weston Holdings, Inc... |
Director |
– • – |
2017-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10 |
2,486 |
0 |
- |
|
| KKD |
Krispy Kreme Doughnuts In... |
Director |
– • – |
2015-03-27 |
4 |
S |
$20.00 |
$445,000 |
D/D |
(22,250) |
0 |
0 |
- |
|
| KKD |
Krispy Kreme Doughnuts In... |
Director |
– • – |
2015-03-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,750 |
22,250 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-17 |
4 |
S |
$21.76 |
$119,666 |
D/D |
(5,500) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-17 |
4 |
OE |
$9.27 |
$50,985 |
D/D |
5,500 |
5,500 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-16 |
4 |
S |
$21.80 |
$207,067 |
D/D |
(9,500) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-16 |
4 |
OE |
$7.10 |
$71,790 |
D/D |
9,500 |
9,500 |
0 |
- |
|
| KKD |
Krispy Kreme Doughnuts In... |
Director |
– • – |
2007-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
24,000 |
0 |
- |
|
| KKD |
Krispy Kreme Doughnuts In... |
General Counsel |
• • – |
2007-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
18,000 |
0 |
- |
|
| KKD |
Krispy Kreme Doughnuts In... |
General Counsel |
• – – |
2006-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| KKD |
Krispy Kreme Doughnuts In... |
General Counsel |
• – – |
2006-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
904,761 |
909,094 |
|
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2006-04-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,333 |
|
- |
|
| RAI |
Reynolds American Inc |
EVP and General Counsel |
• – – |
2005-12-21 |
4 |
S |
$95.05 |
$676,991 |
D/D |
(7,122) |
7,167 |
0 |
- |
|
| RAI |
Reynolds American Inc |
EVP and General Counsel |
• – – |
2005-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,032 |
19,321 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
